Position in BMY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$97,954
-$5,151 QoQ
Shares Held
1,700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#2,245
of 2,506 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advantage Trust Co holds $1,835,316 across 10 Drug Manufacturers - General names. BMY ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
865 | $1,037,507 | |
| 2 | ABBV |
AbbVie Inc.
|
939 | $236,289 | |
| 3 | JNJ |
Johnson & Johnson
|
786 | $199,620 | |
| 4 | PFE |
Pfizer Inc
|
5,353 | $128,900 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
1,700 | $97,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
709 | $91,106 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
138 | $17,434 | |
| 8 | GSK |
GSK plc
|
240 | $12,580 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,954 | 1,700 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $103,105 | 1,700 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $111,871 | 2,074 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $96,153 | 2,132 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $110,771 | 2,393 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $145,949 | 2,393 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $139,986 | 2,475 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $128,056 | 2,475 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $102,786 | 2,475 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $135,683 | 2,502 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $128,377 | 2,502 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||